Tenderwize
Back to tender search

Open-house discount agreement for Urapidil

AOK Bayern - Die Gesundheitskasse·München, Germany·Deadline Dec 03, 2027 · 473 days left·Open·Supplies·Framework
Original notice title

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge Urapidil, ATC C02CA06

52/100

Opportunity Score

Needs reviewMedium complexity
SuppliesFrameworkOpen
Why this score?

Opportunity

52 / 100

Complexity

58 / 100

Risk factors

Incorrect submission channel is explicitly disallowed; the buyer says documents must be submitted via the DTVP communic...

The monthly accession mechanism depends on receipt by the 3rd of the month, and paper originals must arrive by the 10th...

Deep Portfolio Analysis

Deep Company Fit Analysis

Uses:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Overview

Moderate opportunity

Key Facts

  • Framework procurement
  • Supplies contract
  • 1 lot
  • Duration until Jan 2028
  • Non-exclusive open-house discount agreements for the medicinal product Urapidil, ATC C02CA06.
  • Supply of pharmaceutical products under identical, pre-set contract terms.
Show full summary

This is an open-house supply arrangement for pharmaceutical discount agreements on Urapidil (ATC C02CA06) led by AOK Bayern. It is not a competitive award procedure in the usual sense: the buyer states that all interested pharmaceutical companies meeting the stated suitability requirement may join on identical, non-negotiable terms. The contract period runs from 2026-02-01 to 2028-01-31, with contract entry possible at any time until 2027-12-03. Submission is via DTVP electronic communication area with a qualified electronic signature, or by paper originals in duplicate; documents not in German must be submitted with a German translation. No contract value is provided.

Risks

Incorrect submission channel is explicitly disallowed; the buyer says documents must be submitted via the DTVP communic...

The monthly accession mechanism depends on receipt by the 3rd of the month, and paper originals must arrive by the 10th...

Analysis may be incomplete

Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.

Key Requirements

Technical

  • The contract and the annex 'Festlegung der vertragsgegenständlichen Arzneimittel' must be completed and signed.

Eligibility

  • Only pharmaceutical companies are eligible as potential contract partners.

Administrative

  • A signed declaration of reliability (Eigenerklärung zur Zuverlässigkeit) must be submitted.

Buyer

Location

München, DEU

Website

www.aok.de

Buyer profile

Open profile

Identifier

DE811695320

Activity

Health

Lots (1)

LOT-0001

Open-house discount agreement for Urapidil

Open-house pharmaceutical discount agreement for the active substance Urapidil (ATC C02CA06). The lot is described as a supply arrangement for pharmaceutical products. The buyer states that the contract is non-exclusive, identical for all eligible companies, and not individually negotiable. Performance is in Germany, specifically the Bavaria region (DE212).

SuppliesFrameworkEU fundedElectronic submission

Location

DE212, Germany

Duration

Jan 2026 - Jan 2028

Category

Pharmaceutical products

Deadline

Deadline Dec 03, 2027

Procurement Details

Publication date
14 Dec 2025
Languages
German

Reference metadata

Legal basis
32014L0024

Reference IDs

Tender ID
831448-2025

Documents (2)

Similar tenders